Safety profiles of anti-VEGF drugs: bevacizumab, ranibizumab, aflibercept and ziv-aflibercept on human retinal pigment epithelium cells in culture

PURPOSE: To compare the safety profiles of antivascular endothelial growth factor (VEGF) drugs ranibizumab, bevacizumab, aflibercept and ziv-aflibercept on retinal pigment epithelium cells in culture. METHODS: Human retinal pigment epithelium cells (ARPE-19) were exposed for 24 h to four anti-VEGF d...

Descripción completa

Detalles Bibliográficos
Autores principales: Malik, Deepika, Tarek, Mohamed, Caceres del Carpio, Javier, Ramirez, Claudio, Boyer, David, Kenney, M Cristina, Kuppermann, Baruch D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033208/
https://www.ncbi.nlm.nih.gov/pubmed/24836865
http://dx.doi.org/10.1136/bjophthalmol-2014-305302

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033208/
https://www.ncbi.nlm.nih.gov/pubmed/24836865
http://dx.doi.org/10.1136/bjophthalmol-2014-305302

Ejemplares similares